Literature DB >> 27714538

Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal Cancer.

Katsushi Takebayashi1,2, Yasuhiro Tsubosa1, Tomoyuki Kamijo3, Yoshiyuki Iida2, Atsushi Imai2, Masato Nagaoka2, Takashi Kitani2, Masahiro Niihara1, Eisuke Booka1, Ayako Shimada1, Masahiro Nakagawa4, Tetsuro Onitsuka2.   

Abstract

BACKGROUND: Total pharyngolaryngectomy and cervical esophagectomy (TPLCE) after chemoradiotherapy remains a challenge because of the high rate of complications and few available data on outcomes and safety. The purpose of this study was to evaluate the clinical significance of salvage TPLCE and to compare treatment outcomes between hypopharyngeal cancer and cervical esophageal cancer.
METHODS: Data from 37 consecutive patients who were diagnosed with potentially resectable hypopharyngeal and cervical esophageal cancer after chemoradiotherapy were retrospectively analyzed. The survival and surgical outcomes were investigated between the hypopharyngeal cancer and cervical esophageal cancer groups.
RESULTS: Twenty-six patients were included in hypopharyngeal cancer group and 11 patients were included in cervical esophageal cancer group. The baseline characteristics were balanced between the two groups. Compared to the hypopharyngeal cancer group, the cervical esophageal cancer group had significantly more frequent tracheal-related complications (p < 0.05) and stronger association of distal margin of the cervical esophagus and radiation field with tracheal ischemia after salvage surgery.
CONCLUSIONS: Salvage TPLCE can offer the exclusive chance of prolonged survival. Association of tracheal ischemia with salvage TPLCE was seen more frequently for cervical esophageal cancer. Therefore, the indication for salvage TPLCE must be carefully considered to maintain the balance between curability and safety.

Entities:  

Mesh:

Year:  2016        PMID: 27714538     DOI: 10.1245/s10434-016-5474-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Treatment outcomes for one-stage concurrent surgical resection and reconstruction of synchronous esophageal and head and neck squamous cell carcinoma.

Authors:  Yu-Hsuan Lin; Chun-Yen Ou; Wei-Ting Lee; Yao -Chou Lee; Tzu -Yen Chang; Yi-Ting Yen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-22       Impact factor: 2.503

Review 2.  Cervical Esophageal Cancers: Challenges and Opportunities.

Authors:  Michael Buckstein; Jerry Liu
Journal:  Curr Oncol Rep       Date:  2019-04-04       Impact factor: 5.075

Review 3.  Update on Management of Squamous Cell Esophageal Cancer.

Authors:  John K Waters; Scott I Reznik
Journal:  Curr Oncol Rep       Date:  2022-02-10       Impact factor: 5.075

4.  Induction chemotherapy for the individualised treatment of hypopharyngeal carcinoma with cervical oesophageal invasion: a retrospective cohort study.

Authors:  Tian-Qiao Huang; Ru Wang; Ju-Gao Fang; Shi-Zhi He; Qi Zhong; Li-Zhen Hou; Hong-Zhi Ma; Xiao-Hong Chen; Xue-Jun Chen; Ping-Dong Li; Ling Feng; Qian Shi; Meng Lian
Journal:  World J Surg Oncol       Date:  2020-12-11       Impact factor: 2.754

5.  Definitive Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil for Advanced Cervical Esophageal Cancer: A Medium-Term Outcome.

Authors:  Hiroshi Okamoto; Yusuke Taniyama; Chiaki Sato; Toshiaki Fukutomi; Yohei Ozawa; Ryohei Ando; Kozue Takahashi; Ryujiro Akaishi; Yuta Horie; Yasuharu Shinozaki; Michiaki Unno; Takashi Kamei
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.